Global Longlife Hospital And Research Ltd vs Indegene Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Global Longlife Hospital and Research Ltd is ₹ 12.57 as of 23 Oct 15:30 . The P/E Ratio of Global Longlife Hospital and Research Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Indegene Ltd changed from 34 on March 2025 to 26 on March 2026 . This represents a CAGR of -12.55% over 2 years The Market Cap of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Indegene Ltd changed from ₹ 13878 crore on March 2025 to ₹ 10469 crore on March 2026 . This represents a CAGR of -13.14% over 2 years The revenue of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Indegene Ltd for the Jun '26 is ₹ 1092 crore as compare to the Mar '26 revenue of ₹ 1014 crore. This represent the growth of 7.68% The ebitda of Global Longlife Hospital and Research Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Indegene Ltd for the Jun '26 is ₹ 203.2 crore as compare to the Mar '26 ebitda of ₹ 154.1 crore. This represent the growth of 31.86% The net profit of Global Longlife Hospital and Research Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Indegene Ltd changed from ₹ 87.7 crore to ₹ 116.2 crore over 9 quarters. This represents a CAGR of 13.32% The Dividend Payout of Global Longlife Hospital and Research Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Indegene Ltd changed from 26.42 % on March 2025 to 25.54 % on March 2026 . This represents a CAGR of -1.68% over 2 years .

About Global Longlife Hospital and Research Ltd

Global Longlife Hospital and Research Limited was originally incorporated as 'Global Longlife Hospital and Research Private Limited' on January 20, 2012 with Registrar of Companies, Gujarat.
Subsequently, Company was converted into a Public Limited Company and , name of the Company was changed to 'Global Longlife Hospital and Research Limited' vide fresh Certificate of Incorporation dated August 31, 2021. The Company had acquired 1339 sq.mt. area land in the prime locality of Ahmedabad for starting hospital in March 2012.
The Hospital started journey in 2015 & determined to build an institution in Ahmedabad.
Mr. Dhruv Jani had also joined the hospital business with his father in July 2015.
The majority Equity shares of the Company were taken over by the present Promoters by acquiring the Equity shares from the Doctors and investors in the year 2017.

About Indegene Ltd

Indegene Limited was incorporated as Indegene Lifesystems Private Limited' at Ahmedabad, Gujarat, as a Private Limited Company, dated October 16, 1998 at Ahmedabad.
Subsequently, name of the Company was changed to Indegene Private Limited' and a fresh Certificate of Incorporation was issued by the Registrar of Companies, Maharashtra at Mumbai on May 26, 2016.
Thereafter, Company converted to a Public Company with change in name to Indegene Limited' on November 17, 2022. The Company is a digital-first life sciences commercialization company, enabling biopharmaceutical, emerging biotech, and medical device companies to develop, launch, and scale the impact of their products with greater speed, precision, and efficiency.
As a specialized company, it combine healthcare domain expertise, fit-for-purpose technology, and an agile operating model to solve the most complex problems in the healthcare industry.

FAQs for the comparison of Global Longlife Hospital and Research Ltd and Indegene Ltd

Which company has a larger market capitalization, Global Longlife Hospital and Research Ltd or Indegene Ltd?

Market cap of Global Longlife Hospital and Research Ltd is 13 Cr while Market cap of Indegene Ltd is 13,768 Cr

What are the key factors driving the stock performance of Global Longlife Hospital and Research Ltd and Indegene Ltd?

The stock performance of Global Longlife Hospital and Research Ltd and Indegene Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Global Longlife Hospital and Research Ltd and Indegene Ltd?

As of October 25, 2026, the Global Longlife Hospital and Research Ltd stock price is INR ₹12.57. On the other hand, Indegene Ltd stock price is INR ₹571.5.

How do dividend payouts of Global Longlife Hospital and Research Ltd and Indegene Ltd compare?

To compare the dividend payouts of Global Longlife Hospital and Research Ltd and Indegene Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.